Gene Symbol | Gene ID | Gene Info |
---|---|---|
LHX2
|
ENSG00000106689.6 | LIM homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_126759855_126760197 | LHX2 | 3923 | 0.195546 | -0.63 | 7.0e-02 | Click! |
chr9_126773746_126773955 | LHX2 | 39 | 0.947237 | -0.51 | 1.6e-01 | Click! |
chr9_126774768_126775305 | LHX2 | 400 | 0.790921 | -0.47 | 2.1e-01 | Click! |
chr9_126781132_126781283 | LHX2 | 3531 | 0.195483 | -0.45 | 2.2e-01 | Click! |
chr9_126777225_126777376 | LHX2 | 376 | 0.829399 | -0.35 | 3.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_148829582_148830289 | 0.82 |
ENSG00000223322 |
. |
15441 |
0.29 |
chr7_93550787_93551002 | 0.71 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
117 |
0.96 |
chr4_54063057_54063462 | 0.69 |
ENSG00000207385 |
. |
68475 |
0.13 |
chr14_45433796_45433989 | 0.68 |
FAM179B |
family with sequence similarity 179, member B |
2450 |
0.23 |
chr15_48935948_48936126 | 0.67 |
FBN1 |
fibrillin 1 |
1881 |
0.46 |
chr4_114898942_114899097 | 0.64 |
ARSJ |
arylsulfatase family, member J |
1133 |
0.61 |
chr11_132863892_132864419 | 0.62 |
OPCML |
opioid binding protein/cell adhesion molecule-like |
50492 |
0.18 |
chr8_89338531_89338740 | 0.61 |
RP11-586K2.1 |
|
430 |
0.76 |
chr6_85470567_85470756 | 0.58 |
TBX18 |
T-box 18 |
2412 |
0.42 |
chr10_128249841_128250268 | 0.58 |
ENSG00000221717 |
. |
4421 |
0.3 |
chr4_81191052_81191243 | 0.56 |
FGF5 |
fibroblast growth factor 5 |
3354 |
0.31 |
chr13_103478539_103479046 | 0.56 |
ENSG00000222301 |
. |
6449 |
0.13 |
chr7_94025506_94025990 | 0.55 |
COL1A2 |
collagen, type I, alpha 2 |
1875 |
0.46 |
chr22_45900582_45901194 | 0.55 |
FBLN1 |
fibulin 1 |
1962 |
0.36 |
chr11_12529707_12530128 | 0.55 |
PARVA |
parvin, alpha |
55635 |
0.15 |
chr4_4494063_4494282 | 0.54 |
STX18-IT1 |
STX18 intronic transcript 1 (non-protein coding) |
10745 |
0.21 |
chr2_175710742_175710893 | 0.54 |
CHN1 |
chimerin 1 |
316 |
0.93 |
chr11_36252522_36252860 | 0.53 |
COMMD9 |
COMM domain containing 9 |
58283 |
0.13 |
chr4_160170135_160170337 | 0.51 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
17797 |
0.23 |
chr6_130392038_130392189 | 0.51 |
L3MBTL3 |
l(3)mbt-like 3 (Drosophila) |
50411 |
0.15 |
chr4_138449879_138450179 | 0.51 |
PCDH18 |
protocadherin 18 |
3536 |
0.4 |
chr13_100225293_100225444 | 0.50 |
CLYBL |
citrate lyase beta like |
33551 |
0.14 |
chr4_99578140_99578845 | 0.50 |
TSPAN5 |
tetraspanin 5 |
294 |
0.89 |
chr2_229517064_229517215 | 0.50 |
ENSG00000251801 |
. |
64550 |
0.15 |
chr2_227049788_227050011 | 0.50 |
ENSG00000263363 |
. |
473610 |
0.01 |
chr3_115961041_115961192 | 0.50 |
LSAMP-AS1 |
LSAMP antisense RNA 1 |
117755 |
0.07 |
chr12_59310321_59310512 | 0.49 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2052 |
0.37 |
chr22_36235496_36235773 | 0.48 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
631 |
0.82 |
chr7_16709331_16709660 | 0.48 |
BZW2 |
basic leucine zipper and W2 domains 2 |
7737 |
0.2 |
chr15_96885905_96886056 | 0.47 |
ENSG00000222651 |
. |
9490 |
0.16 |
chr12_26147598_26147778 | 0.47 |
RASSF8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
249 |
0.94 |
chr8_93082068_93082219 | 0.47 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
1472 |
0.57 |
chr12_43741404_43741555 | 0.46 |
ENSG00000215993 |
. |
56096 |
0.16 |
chr15_42749459_42749764 | 0.46 |
ZNF106 |
zinc finger protein 106 |
100 |
0.96 |
chr17_13503089_13503240 | 0.46 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
2080 |
0.42 |
chr5_95068559_95068710 | 0.46 |
CTD-2154I11.2 |
|
635 |
0.64 |
chr4_121990444_121990801 | 0.46 |
NDNF |
neuron-derived neurotrophic factor |
2534 |
0.31 |
chr4_86790910_86791061 | 0.45 |
ENSG00000265774 |
. |
40711 |
0.17 |
chr4_77611462_77611724 | 0.45 |
AC107072.2 |
|
52817 |
0.12 |
chr12_59312115_59312531 | 0.45 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
1004 |
0.56 |
chr2_33822690_33822841 | 0.45 |
FAM98A |
family with sequence similarity 98, member A |
1579 |
0.47 |
chr19_13137194_13137536 | 0.44 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1554 |
0.23 |
chr1_117636227_117636430 | 0.44 |
ENSG00000215930 |
. |
937 |
0.49 |
chr18_74409526_74409726 | 0.44 |
ENSG00000252097 |
. |
103104 |
0.07 |
chr1_196621837_196622284 | 0.43 |
CFH |
complement factor H |
874 |
0.67 |
chr2_219435462_219435613 | 0.43 |
RQCD1 |
RCD1 required for cell differentiation1 homolog (S. pombe) |
1939 |
0.2 |
chr6_86159887_86160764 | 0.43 |
NT5E |
5'-nucleotidase, ecto (CD73) |
498 |
0.87 |
chr13_33779104_33779430 | 0.42 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
876 |
0.67 |
chr8_116675050_116675578 | 0.42 |
TRPS1 |
trichorhinophalangeal syndrome I |
1409 |
0.6 |
chr14_101294075_101294314 | 0.42 |
AL117190.2 |
|
1343 |
0.15 |
chr11_91714959_91715138 | 0.42 |
FAT3 |
FAT atypical cadherin 3 |
370214 |
0.01 |
chr3_157157796_157157947 | 0.41 |
PTX3 |
pentraxin 3, long |
3293 |
0.33 |
chr17_76036766_76037651 | 0.41 |
TNRC6C |
trinucleotide repeat containing 6C |
80 |
0.97 |
chr1_201509442_201509672 | 0.41 |
CSRP1 |
cysteine and glycine-rich protein 1 |
30973 |
0.13 |
chr10_69832583_69833003 | 0.41 |
HERC4 |
HECT and RLD domain containing E3 ubiquitin protein ligase 4 |
1101 |
0.53 |
chr1_119521934_119522435 | 0.41 |
TBX15 |
T-box 15 |
8244 |
0.28 |
chr10_90041933_90042089 | 0.41 |
ENSG00000200891 |
. |
287559 |
0.01 |
chrX_34671991_34672311 | 0.40 |
TMEM47 |
transmembrane protein 47 |
3254 |
0.41 |
chr7_15723235_15723386 | 0.40 |
MEOX2 |
mesenchyme homeobox 2 |
3127 |
0.32 |
chr11_122050333_122050506 | 0.40 |
ENSG00000207994 |
. |
27403 |
0.16 |
chrX_115371447_115371702 | 0.40 |
AGTR2 |
angiotensin II receptor, type 2 |
69599 |
0.13 |
chr22_29489752_29489903 | 0.40 |
CTA-747E2.10 |
|
17844 |
0.13 |
chr1_179111271_179111703 | 0.40 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
692 |
0.72 |
chr12_20525245_20525493 | 0.39 |
RP11-284H19.1 |
|
2173 |
0.35 |
chr15_81073340_81073491 | 0.39 |
KIAA1199 |
KIAA1199 |
1703 |
0.42 |
chr5_172753672_172753903 | 0.39 |
STC2 |
stanniocalcin 2 |
13 |
0.98 |
chr13_24778161_24778312 | 0.39 |
ENSG00000252695 |
. |
41681 |
0.13 |
chr16_69478979_69479169 | 0.39 |
CYB5B |
cytochrome b5 type B (outer mitochondrial membrane) |
20388 |
0.15 |
chr10_728995_729174 | 0.39 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
6522 |
0.18 |
chr21_32715523_32716836 | 0.39 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
415 |
0.91 |
chr10_70321971_70322188 | 0.39 |
TET1 |
tet methylcytosine dioxygenase 1 |
1666 |
0.36 |
chr1_70818696_70818847 | 0.39 |
ANKRD13C |
ankyrin repeat domain 13C |
1634 |
0.29 |
chr12_18449684_18450065 | 0.39 |
PIK3C2G |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
14896 |
0.31 |
chr21_37312564_37312715 | 0.39 |
FKSG68 |
|
41912 |
0.14 |
chr17_63549735_63549886 | 0.39 |
AXIN2 |
axin 2 |
5037 |
0.32 |
chr3_79066759_79066910 | 0.39 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
860 |
0.75 |
chr5_102209163_102209314 | 0.39 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
7418 |
0.33 |
chr12_91575190_91575391 | 0.39 |
DCN |
decorin |
537 |
0.85 |
chr17_18090882_18091033 | 0.39 |
RP11-258F1.1 |
|
2890 |
0.16 |
chr12_91576386_91576586 | 0.38 |
DCN |
decorin |
0 |
0.99 |
chr1_247611615_247612128 | 0.38 |
OR2B11 |
olfactory receptor, family 2, subfamily B, member 11 |
3437 |
0.2 |
chr11_19736431_19736825 | 0.38 |
NAV2 |
neuron navigator 2 |
1485 |
0.49 |
chr3_157158697_157158863 | 0.38 |
PTX3 |
pentraxin 3, long |
4202 |
0.3 |
chr10_120031586_120031737 | 0.38 |
FAM204A |
family with sequence similarity 204, member A |
70091 |
0.13 |
chr16_64450080_64450292 | 0.38 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
643395 |
0.0 |
chr16_59668238_59668389 | 0.38 |
ENSG00000200062 |
. |
94283 |
0.09 |
chr1_34629900_34630098 | 0.38 |
CSMD2 |
CUB and Sushi multiple domains 2 |
876 |
0.55 |
chr10_33670460_33670611 | 0.38 |
NRP1 |
neuropilin 1 |
45345 |
0.19 |
chr7_137028318_137028638 | 0.38 |
PTN |
pleiotrophin |
42 |
0.99 |
chr10_30504590_30504756 | 0.37 |
ENSG00000200887 |
. |
83929 |
0.09 |
chr1_156087932_156088663 | 0.37 |
LMNA |
lamin A/C |
3784 |
0.13 |
chr11_119292436_119293234 | 0.37 |
THY1 |
Thy-1 cell surface antigen |
437 |
0.74 |
chr4_122077287_122077641 | 0.37 |
TNIP3 |
TNFAIP3 interacting protein 3 |
8031 |
0.23 |
chr13_45146263_45146555 | 0.37 |
TSC22D1 |
TSC22 domain family, member 1 |
3983 |
0.32 |
chr9_98335013_98335164 | 0.37 |
PTCH1 |
patched 1 |
55749 |
0.12 |
chr10_33622034_33622426 | 0.37 |
NRP1 |
neuropilin 1 |
1080 |
0.63 |
chr2_238322401_238322657 | 0.37 |
COL6A3 |
collagen, type VI, alpha 3 |
262 |
0.93 |
chr8_24366535_24366686 | 0.37 |
RP11-561E1.1 |
|
5491 |
0.24 |
chr18_32075591_32075742 | 0.36 |
DTNA |
dystrobrevin, alpha |
1799 |
0.52 |
chr13_91965562_91965713 | 0.36 |
ENSG00000215417 |
. |
37222 |
0.22 |
chr3_134091064_134091340 | 0.36 |
AMOTL2 |
angiomotin like 2 |
448 |
0.85 |
chr6_148831295_148831530 | 0.36 |
ENSG00000223322 |
. |
13964 |
0.3 |
chr3_29566924_29567075 | 0.36 |
RBMS3-AS2 |
RBMS3 antisense RNA 2 |
91547 |
0.09 |
chr6_128841955_128842296 | 0.36 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
255 |
0.91 |
chr2_40591154_40591305 | 0.36 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
66191 |
0.13 |
chr2_227658547_227658788 | 0.36 |
IRS1 |
insulin receptor substrate 1 |
5808 |
0.22 |
chr15_57509304_57509455 | 0.36 |
TCF12 |
transcription factor 12 |
2249 |
0.41 |
chr21_17497567_17497931 | 0.36 |
ENSG00000252273 |
. |
89920 |
0.1 |
chr15_37395216_37395447 | 0.35 |
MEIS2 |
Meis homeobox 2 |
1827 |
0.38 |
chr1_54232654_54232848 | 0.35 |
ENSG00000201003 |
. |
4075 |
0.22 |
chr6_18749403_18749554 | 0.35 |
ENSG00000207775 |
. |
177463 |
0.03 |
chr1_162791853_162792918 | 0.35 |
HSD17B7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
31806 |
0.15 |
chr5_71543858_71544009 | 0.35 |
ENSG00000244748 |
. |
66582 |
0.09 |
chr18_10059803_10059983 | 0.35 |
ENSG00000263630 |
. |
54699 |
0.15 |
chr7_94026391_94026542 | 0.35 |
COL1A2 |
collagen, type I, alpha 2 |
2593 |
0.39 |
chr14_52122431_52122582 | 0.35 |
FRMD6 |
FERM domain containing 6 |
3808 |
0.24 |
chr11_108766543_108766821 | 0.35 |
ENSG00000201243 |
. |
109562 |
0.07 |
chr9_17005379_17005546 | 0.35 |
ENSG00000241152 |
. |
48437 |
0.18 |
chr9_99277013_99277426 | 0.35 |
CDC14B |
cell division cycle 14B |
51893 |
0.13 |
chr3_29327656_29328192 | 0.35 |
RBMS3-AS3 |
RBMS3 antisense RNA 3 |
4293 |
0.26 |
chr6_127836184_127836541 | 0.35 |
SOGA3 |
SOGA family member 3 |
1397 |
0.51 |
chr7_120726405_120726556 | 0.34 |
ENSG00000212628 |
. |
2613 |
0.31 |
chr18_53070200_53070424 | 0.34 |
TCF4 |
transcription factor 4 |
625 |
0.79 |
chr7_83822532_83822694 | 0.34 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
1604 |
0.57 |
chr12_54672073_54672366 | 0.34 |
CBX5 |
chromobox homolog 5 |
1667 |
0.15 |
chr1_223895189_223895645 | 0.34 |
CAPN2 |
calpain 2, (m/II) large subunit |
4617 |
0.23 |
chr6_132269338_132269679 | 0.34 |
RP11-69I8.3 |
|
2578 |
0.29 |
chr11_89938699_89938850 | 0.34 |
CHORDC1 |
cysteine and histidine-rich domain (CHORD) containing 1 |
3872 |
0.31 |
chr5_158426214_158426386 | 0.34 |
CTD-2363C16.2 |
|
13486 |
0.22 |
chr4_38011358_38011509 | 0.34 |
TBC1D1 |
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
17976 |
0.25 |
chr18_32291325_32291476 | 0.34 |
DTNA |
dystrobrevin, alpha |
1139 |
0.62 |
chr14_67878511_67879217 | 0.34 |
PLEK2 |
pleckstrin 2 |
53 |
0.97 |
chr4_159041557_159041708 | 0.34 |
FAM198B |
family with sequence similarity 198, member B |
39201 |
0.16 |
chr17_48295929_48296104 | 0.34 |
COL1A1 |
collagen, type I, alpha 1 |
17023 |
0.11 |
chr11_124513856_124514050 | 0.33 |
ENSG00000200278 |
. |
7598 |
0.12 |
chr5_15510117_15510353 | 0.33 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
8688 |
0.31 |
chr15_48936207_48936433 | 0.33 |
FBN1 |
fibrillin 1 |
1598 |
0.51 |
chr9_16869648_16869822 | 0.33 |
BNC2 |
basonuclin 2 |
969 |
0.71 |
chr7_95704908_95705546 | 0.33 |
ENSG00000208025 |
. |
143841 |
0.04 |
chr8_122650853_122651057 | 0.33 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
578 |
0.78 |
chr6_57035944_57036095 | 0.33 |
RP11-203B9.4 |
|
172 |
0.92 |
chr13_33896904_33897055 | 0.33 |
ENSG00000264288 |
. |
14130 |
0.21 |
chr11_94527493_94527644 | 0.33 |
AMOTL1 |
angiomotin like 1 |
26031 |
0.2 |
chr1_215130950_215131319 | 0.33 |
KCNK2 |
potassium channel, subfamily K, member 2 |
48064 |
0.2 |
chr7_28312230_28312417 | 0.33 |
CREB5 |
cAMP responsive element binding protein 5 |
26617 |
0.2 |
chr10_95813368_95813519 | 0.33 |
ENSG00000252895 |
. |
6561 |
0.2 |
chr8_67522944_67523356 | 0.33 |
MYBL1 |
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
1992 |
0.31 |
chr20_4953796_4953984 | 0.32 |
SLC23A2 |
solute carrier family 23 (ascorbic acid transporter), member 2 |
28255 |
0.16 |
chr2_104572278_104572429 | 0.32 |
ENSG00000199727 |
. |
576878 |
0.0 |
chr14_45711437_45711895 | 0.32 |
MIS18BP1 |
MIS18 binding protein 1 |
10714 |
0.2 |
chr12_78078846_78079000 | 0.32 |
AC073528.1 |
|
128355 |
0.06 |
chr2_200446222_200446758 | 0.32 |
SATB2 |
SATB homeobox 2 |
110501 |
0.07 |
chr11_23919257_23919465 | 0.32 |
ENSG00000252519 |
. |
48037 |
0.2 |
chr6_159360525_159360963 | 0.32 |
ENSG00000223191 |
. |
13141 |
0.19 |
chr16_89990965_89991193 | 0.32 |
TUBB3 |
Tubulin beta-3 chain |
1305 |
0.26 |
chr20_42667406_42667585 | 0.32 |
TOX2 |
TOX high mobility group box family member 2 |
15496 |
0.21 |
chr3_87036535_87037613 | 0.32 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr12_21926599_21927146 | 0.32 |
KCNJ8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
883 |
0.57 |
chr5_16713364_16713515 | 0.32 |
MYO10 |
myosin X |
25057 |
0.21 |
chr1_42383823_42384248 | 0.31 |
HIVEP3 |
human immunodeficiency virus type I enhancer binding protein 3 |
134 |
0.98 |
chr1_215181172_215181323 | 0.31 |
KCNK2 |
potassium channel, subfamily K, member 2 |
2049 |
0.5 |
chr7_92327766_92328157 | 0.31 |
ENSG00000206763 |
. |
3167 |
0.33 |
chr10_7914212_7914417 | 0.31 |
TAF3 |
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa |
53847 |
0.14 |
chr1_224805331_224805508 | 0.31 |
CNIH3 |
cornichon family AMPA receptor auxiliary protein 3 |
1424 |
0.35 |
chr7_121078096_121078495 | 0.31 |
FAM3C |
family with sequence similarity 3, member C |
41877 |
0.19 |
chr16_15588070_15588221 | 0.31 |
C16orf45 |
chromosome 16 open reading frame 45 |
7978 |
0.23 |
chr1_48174846_48175814 | 0.31 |
FLJ00388 |
|
51960 |
0.16 |
chr2_230138192_230138530 | 0.31 |
PID1 |
phosphotyrosine interaction domain containing 1 |
2360 |
0.4 |
chr6_148664293_148664728 | 0.31 |
SASH1 |
SAM and SH3 domain containing 1 |
781 |
0.74 |
chr9_118915780_118915931 | 0.31 |
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
228 |
0.95 |
chr15_99297407_99297593 | 0.31 |
ENSG00000264480 |
. |
30155 |
0.19 |
chr8_40011594_40011745 | 0.31 |
C8orf4 |
chromosome 8 open reading frame 4 |
680 |
0.81 |
chr14_30696659_30696810 | 0.31 |
PRKD1 |
protein kinase D1 |
35630 |
0.23 |
chr12_127568278_127568473 | 0.31 |
ENSG00000239776 |
. |
82297 |
0.12 |
chr6_152701966_152702349 | 0.31 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
476 |
0.79 |
chr2_161767569_161767862 | 0.31 |
ENSG00000244372 |
. |
33657 |
0.24 |
chr18_7617915_7618177 | 0.30 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
50229 |
0.16 |
chr7_114055046_114055222 | 0.30 |
FOXP2 |
forkhead box P2 |
21 |
0.98 |
chr4_20420225_20420376 | 0.30 |
SLIT2-IT1 |
SLIT2 intronic transcript 1 (non-protein coding) |
26488 |
0.25 |
chr12_95868834_95869163 | 0.30 |
METAP2 |
methionyl aminopeptidase 2 |
1060 |
0.55 |
chr13_36047277_36047487 | 0.30 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
3450 |
0.24 |
chr10_95802235_95802386 | 0.30 |
ENSG00000252895 |
. |
4572 |
0.22 |
chr1_178602075_178602251 | 0.30 |
ENSG00000266417 |
. |
44721 |
0.13 |
chr12_2162213_2162837 | 0.30 |
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
61 |
0.97 |
chr12_91487813_91488090 | 0.30 |
LUM |
lumican |
17657 |
0.21 |
chr15_57978292_57978443 | 0.30 |
POLR2M |
polymerase (RNA) II (DNA directed) polypeptide M |
20460 |
0.23 |
chr15_37176117_37176447 | 0.30 |
ENSG00000212511 |
. |
31441 |
0.23 |
chr8_121137253_121137925 | 0.30 |
COL14A1 |
collagen, type XIV, alpha 1 |
237 |
0.96 |
chr9_112942337_112942488 | 0.30 |
C9orf152 |
chromosome 9 open reading frame 152 |
28057 |
0.2 |
chr1_164534283_164534434 | 0.30 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
2316 |
0.4 |
chr1_100232300_100232564 | 0.30 |
FRRS1 |
ferric-chelate reductase 1 |
1083 |
0.49 |
chr3_15369209_15369360 | 0.30 |
SH3BP5 |
SH3-domain binding protein 5 (BTK-associated) |
4783 |
0.16 |
chr4_183370400_183371073 | 0.30 |
TENM3 |
teneurin transmembrane protein 3 |
584 |
0.84 |
chr16_73247873_73248024 | 0.30 |
C16orf47 |
chromosome 16 open reading frame 47 |
69602 |
0.13 |
chr5_72715930_72716106 | 0.30 |
FOXD1 |
forkhead box D1 |
28334 |
0.19 |
chr3_100711576_100712203 | 0.29 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
408 |
0.89 |
chr2_12861553_12861813 | 0.29 |
TRIB2 |
tribbles pseudokinase 2 |
3319 |
0.32 |
chr6_109397451_109397602 | 0.29 |
ENSG00000199944 |
. |
16709 |
0.17 |
chr5_91941448_91941599 | 0.29 |
ENSG00000221810 |
. |
111697 |
0.07 |
chr11_121970015_121970287 | 0.29 |
ENSG00000207971 |
. |
401 |
0.72 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.3 | 1.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.6 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.6 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.6 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.5 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.4 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 1.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 1.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine development(GO:0060998) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.1 | GO:0035929 | steroid hormone secretion(GO:0035929) corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.1 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.1 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.2 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.2 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.1 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.3 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.6 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0051584 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.6 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.3 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 1.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.0 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.0 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0002669 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.4 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.1 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:1904063 | negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.2 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.2 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0043954 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.1 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.0 | 0.7 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0072172 | ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
0.0 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.5 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.3 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.2 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.0 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.0 | GO:0032109 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.4 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.2 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.0 | GO:0032730 | interleukin-1 alpha production(GO:0032610) regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.0 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.0 | 0.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.1 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.0 | GO:0061217 | positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.0 | GO:0070527 | negative regulation of plasminogen activation(GO:0010757) platelet aggregation(GO:0070527) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0008595 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.0 | 0.0 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.3 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.0 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0010657 | muscle cell apoptotic process(GO:0010657) regulation of muscle cell apoptotic process(GO:0010660) |
0.0 | 0.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.0 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 2.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.4 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.9 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.6 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 3.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 1.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.3 | 1.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.8 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 2.6 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 1.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0046970 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 1.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 2.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.1 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 1.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |